CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 4403330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | Jenkins Annalisa Director | Grant or award · Deferred Restricted Stock Units | +14,947 | 14,947 | ||
| 2024-02-08 | Ekblom Anders Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Ekblom Anders Director | Grant or award · Deferred Restricted Stock Units | +19,471 | 19,471 | ||
| 2024-02-08 | PAKIANATHAN DEEPIKA Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Jacquet Pierre Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Jacquet Pierre Director | Grant or award · Deferred Restricted Stock Units | +15,553 | 15,553 | ||
| 2024-02-08 | Yoskowitz Marc J Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Yoskowitz Marc J Director | Grant or award · Deferred Restricted Stock Units | +14,139 | 14,139 | ||
| 2024-02-08 | Bender Jeremy Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Bender Jeremy Director | Grant or award · Deferred Restricted Stock Units | +16,361 | 16,361 | ||
| 2024-02-08 | Shames Daniel Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | Shames Daniel Director | Grant or award · Deferred Restricted Stock Units | +14,139 | 14,139 | ||
| 2024-02-08 | WYZGA MICHAEL S Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 | ||
| 2024-02-08 | WYZGA MICHAEL S Director | Grant or award · Deferred Restricted Stock Units | +30,783 | 30,783 | ||
| 2024-01-25 | Sermon Charles General Counsel | Grant or award · Share Options (Right to buy) | +245,000 | 245,000 | ||
| 2024-01-25 | Fox Christine Ann Chief Financial Officer | Grant or award · Share Options (Right to buy) | +245,000 | 245,000 | ||
| 2024-01-25 | Hughes-Wilson Alexandra See Remarks | Grant or award · Share Options (Right to buy) | +196,000 | 196,000 | ||
| 2024-01-25 | Lewicki John A. Chief Scientific Officer | Grant or award · Share Options (Right to buy) | +137,000 | 137,000 | ||
| 2024-01-25 | Scots-Knight Denise Chief Executive Officer | Grant or award · Share Options (Right to buy) | +850,000 | 850,000 |
Page 7 of 7 · 139 trades